Demant A/S : Divestment of hearing implants positive from financial perspective
>Divestment of hearing implants to Cochlear - Demant announced the divestment of its hearing implant division to Cochlear for a total consideration of DKK 850m. The business was established in 2007 and consists roughly half of bone-anchored hearing implants (c. 45% market share) and the other half of cochlear implants (<5% global market share). The closing of the divestment is expected in H2 2022. DKK 700m will be paid at closing and DKK 150m within 18 months after cl...William Demant Holding is a holding company. Through its subsidiaries, Co develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. Co. focuses on four areas: Hearing Devices, Diagnostic Instruments, Hearing Implants and Personal Communication. Co.'s hearing devices include Oticon, Bernafon, Sonic, Phonic Ear, and FrontRow. Co.'s Hearing implant consist of Oticon Medical. Co.'s diagnostic instruments include Maico, Interacoustics, Amplivox, Grason-Stadler, MedRx, and Micromedical. Co.'s personal communication consists of Sennheiser Communications.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.